Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
Clostridioides difficile infection (CDI) is one of the most common hospital-acquired infectious diseases with a high mortality rate (6-30%). The treatment of CDI, especially the recurrent form of the disease is still considered a challenge. The FILTRATE randomized controlled trial aims to investigate the safety and efficacy of fecal filtrate transplantation in the treatment of recurrent CDI and compare it with conventional fecal microbiota transplantation (FMT).
Epistemonikos ID: b1c5f1e00861c732b6d9c50a8a015bbebaa0eafc
First added on: May 09, 2024